Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
KDMF
0
NDC API
0
VMF
0
EDQM
0
USP
0
JP
0
Others
0
FDA Orange Book
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. 7-chloro-5-phenyl-1-propargyl-1,4-benzodiazepin-2- One
2. Domar
3. Duna
4. Propazepam
5. Z-905
1. Domar
2. 52463-83-9
3. Pinazepam [inn]
4. Zami 905
5. Duna
6. Z-905
7. 7-chloro-1-propargyl-5-phenyl-2h-1,4-benzodiazepin-2-one
8. 7-chloro-1,3-dihydro-5-phenyl-1-(2-propynyl)-2h-1,4-benzodiazepin-2-one
9. 2h-1,4-benzodiazepin-2-one, 7-chloro-1,3-dihydro-5-phenyl-1-(2-propynyl)-
10. Pinazepam (inn)
11. 7-chloro-2,3-dihydro-5-phenyl-1-propargyl-1h-1,4-benzodiazepin-2-one
12. 2h-1,4-benzodiazepin-2-one, 1,3-dihydro-7-chloro-5-phenyl-1-(2-propynyl)-
13. 5286rbz882
14. Pinazepamum
15. Pinazepamum [inn-latin]
16. Einecs 257-934-9
17. Brn 0758533
18. Dea No. 2883
19. Unii-5286rbz882
20. Domar (tn)
21. 7-chloro-5-phenyl-1-prop-2-ynyl-3h-1,4-benzodiazepin-2-one
22. Pinazepam [mi]
23. Pinazepam [mart.]
24. Pinazepam [who-dd]
25. Schembl155928
26. Chembl1213352
27. Dtxsid3023475
28. Chebi:135315
29. Db13335
30. D07314
31. Q7194856
32. 7-chloro-5-phenyl-1-prop-2-ynyl-1,3-dihydro-benzo[e][1,4]diazepin-2-one
33. 7-chloro-5-phenyl-1-(2-propynyl)-1,3-dihydro-2h-1,4-benzodiazepin-2-one #
34. 7-chloro-5-phenyl-1-(prop-2-yn-1-yl)-2,3-dihydro-1h-1,4-benzodiazepin-2-one
35. 7-chloro-5-phenyl-1-prop-2-yn-1-yl-1,3-dihydro-2h-1,4-benzodiazepin-2-one
| Molecular Weight | 308.8 g/mol |
|---|---|
| Molecular Formula | C18H13ClN2O |
| XLogP3 | 3.1 |
| Hydrogen Bond Donor Count | 0 |
| Hydrogen Bond Acceptor Count | 2 |
| Rotatable Bond Count | 2 |
| Exact Mass | 308.0716407 g/mol |
| Monoisotopic Mass | 308.0716407 g/mol |
| Topological Polar Surface Area | 32.7 Ų |
| Heavy Atom Count | 22 |
| Formal Charge | 0 |
| Complexity | 501 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Anti-Anxiety Agents
Agents that alleviate ANXIETY, tension, and ANXIETY DISORDERS, promote sedation, and have a calming effect without affecting clarity of consciousness or neurologic conditions. ADRENERGIC BETA-ANTAGONISTS are commonly used in the symptomatic treatment of anxiety but are not included here. (See all compounds classified as Anti-Anxiety Agents.)
N - Nervous system
N05 - Psycholeptics
N05B - Anxiolytics
N05BA - Benzodiazepine derivatives
N05BA14 - Pinazepam
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Global Sales Information
ABOUT THIS PAGE
10
PharmaCompass offers a list of Pinazepam API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Pinazepam manufacturer or Pinazepam supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Pinazepam manufacturer or Pinazepam supplier.
A propazepam manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of propazepam, including repackagers and relabelers. The FDA regulates propazepam manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. propazepam API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of propazepam manufacturers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PhamaCompass.
A propazepam supplier is an individual or a company that provides propazepam active pharmaceutical ingredient (API) or propazepam finished formulations upon request. The propazepam suppliers may include propazepam API manufacturers, exporters, distributors and traders.
click here to find a list of propazepam suppliers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PharmaCompass.
A propazepam written confirmation (propazepam WC) is an official document issued by a regulatory agency to a propazepam manufacturer, verifying that the manufacturing facility of a propazepam active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting propazepam APIs or propazepam finished pharmaceutical products to another nation, regulatory agencies frequently require a propazepam WC (written confirmation) as part of the regulatory process.
click here to find a list of propazepam suppliers with Written Confirmation (WC) on PharmaCompass.
propazepam Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of propazepam GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right propazepam GMP manufacturer or propazepam GMP API supplier for your needs.
A propazepam CoA (Certificate of Analysis) is a formal document that attests to propazepam's compliance with propazepam specifications and serves as a tool for batch-level quality control.
propazepam CoA mostly includes findings from lab analyses of a specific batch. For each propazepam CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
propazepam may be tested according to a variety of international standards, such as European Pharmacopoeia (propazepam EP), propazepam JP (Japanese Pharmacopeia) and the US Pharmacopoeia (propazepam USP).
